ESMO Patient Engagement Summit 2024: Call to Action
Advocating together for equal access to optimal care for all patients with cancer in the Asia-Pacific Region
Related Articles
President’s Corner – American Society for Radiation Oncology (ASTRO)
Welcome to ASTRO Presidentās Corner, a new video series where ASTRO President, Sameer Keole, MD, FASTRO, and other ASTRO leadership, will present different topics and…
Collaboration and Research Funding Advancements in Kidney Cancer Advocacy
Advocacy efforts have yielded a dramatic increase in kidney cancer research, according to Elizabeth P. Henske, MD.
Clinical progress in the development of CAR T cells to treat malignant glioma
Journal of Neuro-Oncology – Chimeric antigen receptor (CAR) T cell therapy is an exciting modality of immunotherapy that has revolutionized the treatment of hematologic malignancies.…
Experts Highlight Advances and Future Directions for Adjuvant Ribociclib in HR+/HER2ā Breast Cancer
Experts at the 2024 San Antonio Breast Cancer Symposium discussed knowledge gaps in understanding how best to use ribociclib in treating patients with early breast…
Post-ASH 2024 Highlights | VJHemOnc
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our…
Lancet Breast Cancer Commission Report Addresses Challenges to Reduce Disease Burden
Reshma Jagsi, MD, DPhil, highlights key takeaways from the Lancet Breast Cancer Commission Report and the necessary steps forward emphasized in the report.
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review
Treatment intensification strategies are reshaping the treatment landscape of metastatic castration-resistant prostate cancer. Genomic, molecular, and clinical indicators should be used to identify the optimal…
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial | Journal of Clinical Oncology
Purpose For patients with metastatic hormone-sensitive prostate cancer (mHSPC), delaying progression to castration-resistant disease is important not only for overall survival (OS) but also for…
Overcoming recurrence ā how research is bringing new hope for breast cancer patients
Overcoming recurrence ā how research is bringing new hope for breast cancer patients
